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Abstract 
Background: Intense ultrasound, such as that used for tumor ablation, does not differentiate between cancerous 
and normal cells. A method combining ultrasound and biocompatible gold or magnetic nanoparticles (NPs) was 
developed under in vitro conditions using human breast and lung epithelial cells, which causes ultrasound to prefer‑
entially destroy cancerous cells.
Results: Co‑cultures of BEAS‑2B normal lung cells and A549 cancerous lung cells labeled with green and red fluo‑
rescent proteins, respectively, were treated with focused ultrasound beams with the addition of gold and magnetic 
nanoparticles. There were significantly more necrotic A549 cells than BEAS‑2 cells when gold nanoparticles were 
added to the culture medium [(50.6 ± 15.1) vs. (7.4 ± 2.9) %, respectively, P < 0.01]. This selective damage to cancer 
cells was also observed for MDA‑MB231 breast cancer cells relative to MCF‑10A normal breast cells after treatment 
with magnetic nanoparticles.
Conclusions: The data obtained for different cell lines indicate that nanoparticle‑assisted ultrasound therapy (NAUT) 
could be an effective new tool for cancer‑specific treatment and could potentially be combined with conventional 
methods of cancer diagnosis and therapy to further increase the overall cancer cure rate.
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Background
Cancer is a leading cause of death worldwide. Many can-
cer patients die as a result of the severe side effects of 
chemotherapy or from a drug-resistance-related relapse 
after the original treatment. It has been established that 
a typical tumor has a high degree of heterogeneity and 
can contain more than 100 cell types. If a targeted drug 
is used, certain types of cancer cells may survive and 
become dominant in the tumor, eventually making the 
drug ineffective.
If adequate physical treatment is applied, it should 
reduce not only the side effects but also the growth of 
drug-resistant cancer cells. Radiation therapy is one 
of the standard physical methods of cancer treatment. 
There are various types of radiation therapies, includ-
ing electromagnetic ionizing radiation (gamma-rays and 
X-rays), elementary particle ionizing beam radiation 
(electrons, protons and neutrons), and non-ionizing radi-
ation (photons, microwaves and radio waves). The ioniz-
ing radiation is intended to be directed only at the tumor. 
However, radiation is difficult to focus; therefore, it also 
affects normal tissues when it passes through a patient’s 
body. Normal cells are affected by ionizing radiation, 
which produces undesirable side effects [1]. Moreover, 
ionizing radiation itself may cause DNA mutation in 
normal cells, causing these cells to become cancerous. 
Light is used as non-ionizing radiation in photodynamic 
therapy for tumors, and this method relies on the ability 
of certain photosensitizing dyes to absorb light and con-
vert the energy into cytotoxic molecules, including sin-
glet oxygen [2]. The main limitations of photodynamic 
methods are solid tumor hypoxia [3] and relatively low 
penetration. The other disadvantage of the method is the 
need to avoid light exposure for an extensive period after 
the treatment. Other non-ionizing radiation therapies 
are mainly based on hyperthermia in tumors as a result 
of the higher sensitivity of tumor cells to heat than their 
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normal counterparts [4]. Hyperthermia has been induced 
by gold nanoparticle-assisted laser ablation [5], magnetic 
nanoparticle rotation under an alternating magnetic field 
[6], and high-intensity focused ultrasound (HIFU) [7].
Unlike other methods, focused ultrasound is the 
only non-invasive technology that can be used for local 
tumor ablation deep inside the body without caus-
ing severe harm to overlying skin or adjacent connec-
tive tissues. For conventional HIFU transducers, the 
absorption efficiencies of the acoustic energy are gener-
ally similar for normal and malignant tissues such that 
precise focusing of ultrasound beams is required for 
selective tumor ablation. Moreover, normal tissue near 
the tumor region can still be damaged by high-intensity 
ultrasound waves reflected from interfaces [7]. There-
fore, a new physical method that does not cause DNA 
mutations or destroy normal cells is highly desirable. 
To overcome the drawbacks of HIFU, we developed a 
new technique based on an HIFU instrument and bio-
compatible gold and magnetic nanoparticles (NPs) 
in this study. Our results showed that adding NPs to 
culture media allowed for the use of lower ultrasound 
(US) intensities to treat and kill cells compared with 
those used in conventional US treatment. Nanoparticle-
assisted ultrasound therapy (NAUT) allowed for the 
selective killing of malignant breast and lung epithelial 
cells over their normal counterparts.
Results and discussion
Ultrasound treatment of lung cells
Ultrasound treatment of separate cell monolayers
The effect of ultrasound (US) and gold NPs on cancerous 
(A549) and normal (BEAS-2B) lung cells, as analyzed by 
counting viable cells (Q4) using flow cytometry, is shown 
in Fig. 1.
Flow cytometry data for the propidium iodide viability 
test on BEAS-2B and A549 cells are provided in Fig. 1A, 
C, respectively. The mean numbers of viable BEAS-2B 
and A549 cells for five similar experiments, with calcu-
lated P values, are shown in Fig. 1B–E and Table 1.
The results demonstrate a slight decrease in the per-
centage of live cells from (67.8  ±  3.3) to (57  ±  6.0)  % 
when gold NPs were added to US-treated normal BEAS-
2B cells (Fig. 1B, E; Table 1). Interestingly, the percentage 
of live A549 cancer cells decreased from (60.5 ±  4.0) % 
for US-treated cells to (29.8 ±  7.5)  % for the combina-
tion of US with NPs (Fig.  1D, E; Table  1). These results 
indicate that A549 lung cancer cells are more sensitive 
to the damage caused by US than BEAS-2B normal lung 
cells are. The addition of gold NPs to cell cultures leads to 
a significant increase in cancer cell death and shows the 
synergistic damaging effect of US and nanoparticles. The 
BEAS-2B normal cells appear to be more resistant to this 
effect.
Ultrasound treatment of cell co‑cultures
To compare the effect of ultrasound irradiation on nor-
mal and cancerous cells under identical experimental 
conditions, BEAS-2B and A549 human lung cells were 
co-cultured and modified with fluorescent green and 
red proteins, respectively. Monolayers of the co-culture 
were then treated with US with and without the addition 
of gold NPs. This experiment sought to eliminate pos-
sible differences due to the variations in US treatments 
and culture conditions for cancerous and normal cells. 
To estimate the cell damage, we analyzed trypan blue-
stained cells under an optical microscope. Fluorescent 
and phase-contrast images of trypan blue-stained BEAS-
2B/A549 co-culture treated with different combinations 
of US and gold NPs are shown in Fig. 2A. The mean per-
centage of necrotic BEAS-2B and A549 cells for five simi-
lar experiments is presented in Fig. 2B, D and in Table 2.
Phase-contrast and fluorescence images of the con-
trol (untreated) samples without gold NPs are shown 
in Fig.  2Aa–d. Cells with dark- or blue-colored nuclei 
are necrotic. Only a few dead cells were observed in the 
control samples of either cell line. A few dead BEAS-2B 
cells are shown in Fig. 2Ae–h; these cells underwent US 
treatment without the addition of nanoparticles (Fig. 2B, 
D; Table  2). Under these conditions, the number of 
necrotic A549 cells was approximately (18.8  ±  6.0)  % 
(Fig. 2C, D; Table 2). Fluorescence images of the co-cul-
ture treated with the combination of ultrasound irradia-
tion in the presence of gold NPs are shown in Fig. 2Ai–l. 
The combined treatment of cells resulted in (7.4 ±  3.0) 
and (50.6  ±  15.1)  % necrotic BEAS-2B and A549 cells, 
respectively (Fig.  2B–D; Table  2). Thus, the addition of 
gold NPs to the culture medium immediately before the 
US exposure enhances the damage to both types of lung 
cells. However, the synergistic cytotoxic effects of US and 
NPs are more pronounced on A-549 lung cancer cells 
under co-culture conditions than on their normal coun-
terparts (BEAS-2B cells).
Ultrasound treatment of breast cells
A similar selective killing effect on cancer cells was 
observed when a monolayer of MCF-10A normal breast 
cells and MDA-MB-231 breast cancer cells were treated 
with a combination of US and biocompatible magnetic 
nanoparticles. The flow cytometry data and the mean 
number of live cells for five similar experiments are 
shown in Fig. 3 and Table 3.
The flow cytometry data for MCF-10A normal cells 
and MDA-MB-231 malignant cells are provided in 
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Fig. 1 Flow cytometry data for BEAS‑2B normal lung cells (A) and A549 lung cancer cells (C) after US treatment with gold NPs and the correspond‑
ing numbers of live BEAS‑2B (B, E) and A549 (D, E) cells. A, C Control (untreated) cells without NPs (a); control (untreated) cells with gold NPs (c); 
cells treated with US without NPs (b); cells exposed to US with gold NPs (d). *represents P < 0.05, **represents P < 0.01, ***represents P < 0.001
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Fig.  3A, C, respectively. The number of live cells in Q4 
decreased after US exposure from (81.4 ± 2.7) % for con-
trol samples to (66.3 ± 4.8) % for MCF-10A cells (Fig. 3B, 
E; Table 3) and from (82.6 ± 3.4) % for control samples 
to (55.4  ±  5.1)  % for MDA-MB-231 cells (Fig.  3D, E; 
Table 3). Compared with cells treated with US only, the 
addition of magnetic NPs to the culture media immedi-
ately before US exposure resulted in a reduction in the 
percentage of live MCF-10A cells, from (66.3 ±  4.8) to 
(53 ± 7.1) % (Fig. 3B, E; Table 3), and a decrease in the 
number of live MDA-MB-231 cells, from (55.4 ± 5.1) to 
(34.8 ± 9.8) %. These findings demonstrate that lung and 
breast cells exhibit similar sensitivity to US irradiation, 
as well as to combined treatment with US and gold or 
magnetic NPs.
Transmission electron microscopy images of ultrasound 
treated breast cells
To analyze the type of cell damage caused by US in com-
bination with NPs, TEM images of H-184B5F5/M10 
normal breast cells and MDA-MB-231 breast carcinoma 
cells were obtained (Fig.  4). Images a–c show the nor-
mal breast cells, and images d–f show the cancer cells. 
Images a and d are controls (no ultrasound exposure); 
images b and e are cells treated with ultrasound but not 
NPs. Images c and f depict cells treated with the com-
bination of ultrasound and magnetic NPs. As shown in 
Fig. 4, the membranes of the cancer cells showed a more 
uneven structure after US treatment (Fig.  4e), particu-
larly after treatment with US with NPs (Fig. 4f ), than the 
membranes of the corresponding normal cells (Fig.  4b, 
c, respectively). No nanoparticles were found inside the 
cells.
Analysis of nanoparticle uptake by the cells
To assess whether the enhanced cytotoxicity in lung 
and breast cancer cells is due to uptake of nanoparticles 
by cancer cells before US treatment, inductively cou-
pled plasma mass spectrometry (ICP-MS) analysis of 
NP uptake by four cell lines (the breast cell lines MDA-
MB-231 and MCF-10A and the lung cell lines A549 and 
BEAS-2B) was performed. The results showed similar 
uptake of both NPs by all cell types. However, the uptake 
of gold NPs was approximately 1  % of the amount ini-
tially added to cells by weight. There was a lack of cellular 
uptake of magnetic NPs by all cell lines. The conditions 
of cell sample preparation for the ICP-MS analysis were 
similar to the experimental conditions for the US treat-
ment of cells.
Gold and super-paramagnetic iron oxide NPs possess 
a unique combination of physical and chemical prop-
erties, allowing these NPs to act as highly multifunc-
tional anti-cancer agents. Gold NPs have been tested 
as drug carriers [8], photothermal contrast agents [5], 
and radio-sensitizers [9]. The location of gold NPs in 
the body can also be determined using photoacoustic 
imaging [10], or optical coherence tomography [11] 
in combination with X-ray imaging [12] or electron 
microscopy [13]. Magnetic iron oxide NPs have been 
used as magnetic resonance imaging (MRI) contrast 
agents [14], for magnetic hyperthermia treatment of 
cancer [15], and as magnetic drug carriers [16]. The 
advantages of biocompatible gold and magnetic NPs 
are their low toxicity and their ability to be used as con-
trast agents for various diagnostic methods for visual-
izing tumor tissues.
In addition to thermal effects [17], ultrasound radia-
tion is known to produce mechanical pressure that 
results in acoustic streaming and cavitation within 
cellular systems [18, 19]. Free cavitation bubbles are 
formed in liquid media when the local liquid pressure 
drops below the saturated vapor pressure during the 
rarefaction period of the propagated ultrasound wave. 
The inertial cavitation process leads to the creation of 
shock waves, sonoluminescence and the formation of 
free radicals, which can irreversibly damage cells [20]. 
It is known that the threshold of inertial cavitation can 
be reduced by adding nucleation agents and changing 
the host fluid parameters [21, 22]. NPs may act as a per-
manent source of nucleation sites for cavitating bubbles, 
leading to the enhancement of inertial cavitation in cul-
ture media.
The extracellular effect of NPs was demonstrated by 
ICP-MS analyses. Both lung and breast cell lines exhib-
ited low cellular uptake of gold NPs and a lack of cellular 
uptake for magnetic NPs. No visible magnetic nanopar-
ticles were observed in breast cells based on TEM imag-
ing. The fact that the most substantial cell damage was 
observed when NPs were added to the cell culture 
immediately before US treatment provides indirect 
Table 1 Percentage of  live BEAS-2B and  A549 cells in  separate monolayers treated with  US and  gold NPs averaged 
for five similar experiments
Cell line Percentage of live cells  
not treated with NPs
Percentage of live  
cells treated with NPs
Percentage of live cells  
treated with US alone
Percentage of live cells 
treated with US and NPs
BEAS‑2B 78.6 ± 1.4 80.9 ± 1.8 67.8 ± 3.3 57 ± 6.0
A549 82.7 ± 1.5 79.8 ± 1.8 60.5 ± 3.9 29.8 ± 7.5
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Fig. 2 Phase‑contrast and fluorescence images of trypan blue stained BEAS‑2B and A549 co‑cultures with and without US exposure (A) and the 
corresponding numbers of necrotic BEAS‑2B (B, D) and A549 (C, D) cells. A Control (untreated) cells (a–d); cells treated only with US (e–h); cells 
treated with US and gold NPs (i–l); fluorescence images of normal cells (green) (a, e, i) and cancer cells (red) (b, f, j); phase‑contrast images of the co‑
culture (c, g, k); merged fluorescence and phase‑contrast images (d, h, l). *represents P < 0.05, and **represents P < 0.01
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evidence that the effects are due primarily to an extracel-
lular effect. Increasing the cell incubation time with NPs 
resulted in higher viability of the cells after US exposure 
(data not shown).
It is known that malignant and normal cells differ 
in their metabolism and morphology [23]. The resist-
ances of cancer and normal cells to physical stress are 
known to be different [24]. This conclusion is consist-
ent with our experimental results and may explain 
why under the tension/compression force of ultra-
sound, cancer cells were preferentially damaged. This 
experiment shows that US exposure causes some cell 
damage to both normal and cancer cell types, but the 
effect is greater for cancer cells. This effect was dem-
onstrated for A549 lung cancer cells in co-culture with 
their normal counterparts (BEAS-2B cells). The prefer-
ential destruction of cancer cell membranes was also 
observed in the TEM images of breast cells pre-incu-
bated with magnetic NPs. However, the exact mecha-
nism underlying the selective damage to cancer cells 
requires further investigation.
Although we used two pairs of “malignant/normal” 
lung and breast cell lines, two different types of NPs (gold 
and magnetic) and two types of cell treatment (in sepa-
rate and co-cultured monolayers), selective killing of can-
cer cells was observed throughout the study. This finding 
may indicate that a combination of certain types of NPs 
with US fields could become a universal tool for cancer 
treatment.
Recently, we tried to apply NAUT to xenograft mouse 
model and observed the similar effect. Detailed will be 
published separately.
Conclusions
In this study, we added NPs to cell cultures to determine 
whether the addition specifically enhanced the killing of 
cancer cells with low-intensity ultrasound. Our results 
showed that the addition of NPs indeed enhanced the 
killing of lung and breast cancer cells while largely spar-
ing their normal counterparts in a co-culture system. 
Our discovery suggests that the power of US can be 
reduced relative to that used for HIFU ablation. For the 
treatment of malignant tumors in vivo, a decrease in US 
power would be valuable because it would allow for the 
selective destruction of cancer cells while sparing nearby 
healthy tissues and would reduce the reflection of US 




Gold nanoparticles (10  nm) were obtained from BBI 
International (Ted Pella, Redding, CA).
A TEM image of gold nanoparticles is shown in Fig. 5. 
Each individual nanoparticle can be clearly observed.
Preparation of magnetic nanoparticles
A mixed solution of ferrous and ferric ions in a molar 
ratio of 1:2 was prepared by dissolving 1.13  mmol 
FeCl2 × 4H2O and 2.26 mmol FeCl3 × 6H2O in an 80 cm3 
aqueous solution of poly(vinylalcohol) (PVA) at 80  °C. 
PVA with an average molecular weight of 88,000 (Acros 
Organics) was used to obtain aqueous solutions at con-
centrations of up to 14 g dm−3. Magnetic iron oxide was 
precipitated by adding 0.5  mol  dm−3 of NaOH to the 
above-mentioned mixture while heating to 80  °C and 
stirring with a magnetic stirrer. The mixture was subse-
quently incubated at 80 °C for 30 min and cooled to room 
temperature. The synthesis was performed in an oxygen-
free environment.
Transmission electron microscopy
Transmission electron microscopy (TEM) was per-
formed with a JEM-2100F (JEOL, Japan) instrument 
operating at an accelerating voltage of 75  kV. To pre-
pare samples for TEM, a drop of the suspension 
(0.12 mg mL−1) was placed on a copper grid and dried 
under ambient conditions. The typical size of the metal 
core of magnetic NPs was approximately 4–6  nm and 
was narrowly distributed.
Dynamic light scattering
A DynaPro NanoStar light scattering spectrometer 
(Wyatt Technology, Taiwan) with an emission laser wave-
length of 658 nm was used to measure the hydrodynamic 
diameter of the ferrofluid. All of the measurements were 
performed at an angle of 90°. The hydrodynamic size of 
magnetic NPs was estimated to be 140 nm.
Magnetometry
A drop of magnetic NPs (80  μL) was deposited onto a 
small piece of cotton and dried at room temperature for 
3 days. The sample was inserted into a gelatin capsule and 
fixed inside to avoid any shifts. The saturation magneti-
zation of the sample was measured with a superconduct-
ing quantum interference device (SQUID) magnetometer 
(Quantum Design, MPMS5) at room temperature (300 K) 
Table 2 Percentage of  necrotic BEAS-2B and  A549 cells 
in  co-culture treated with  a combination of  US and  gold 
NPs
The number is the average for five similar experiments
Cell line No NP and no US US but no NP US and NPs
BEAS‑2B 1.4 ± 0.9 2.6 ± 1.2 7.4 ± 2.9
A549 2 ± 1.6 18.8 ± 5.9 50.6 ± 15.1
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Fig. 3 Flow cytometry data for MCF‑10A normal breast cells (A) and MDA‑MB‑231 breast cancer cells (C) with/without US treatment and magnetic 
NPs and the corresponding numbers of live MCF‑10A (B, E) and MDA‑MB‑231 (D, E) cells. A, C Control (untreated) cells not treated with NPs (a); cells 
treated with US alone (b); cells exposed to US and magnetic NPs (c). *represents P < 0.05, **represents P < 0.01, ***represents P < 0.001
with a magnetic field of 7  T. The saturation magnetiza-
tion was estimated to be 54.87 emu g−1 of iron mass. The 
anhysteretic magnetization curve corresponded to the 
superparamagnetic properties of the NPs.
Cell culture
Human A549 lung alveolar adenocarcinoma and BEAS-
2B immortalized human bronchial epithelial cells were 
obtained from ATCC® (Manassas, VA, USA). The A549 
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cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) with 10  % fetal bovine serum (FBS). Defined 
Keratinocyte-SFM culture medium (KSFM; Gibco® Cell 
Culture, USA) was used for the BEAS-2B cells. The cells 
were cultured separately in a monolayer fashion with con-
centrations of 5 × 105 cells mL−1 per well and in a co-cul-
ture (1:1) with a total concentration of 4 × 105 cells mL−1. 
The detailed steps of the protocol are as follows.
Step 1 A549 and BEAS-2B were infected with lentivi-
rus contain green and red fluorescent protein genes, 
respectively, and selected with neomycin (G418) at 
800  μg per mL until fluorescent cells survived and 
grew to confluency. Green fluorescent protein (GFP) 
gene cDNA was constructed into a lentiviral pack-
aging vector to become pLAS2w.GFP-C.Pneo, and 
red fluorescent protein (RFP) gene cDNA was con-
structed to become pLAS2w.RFP-C.Pneo.
Step 2 Each cell line was plated with 2.5  ×  105 cells 
in the same well of a 12-well plate with 10  % FBS 
DMEM medium overnight at 37 °C in 5 % CO2. Every 
well contained approximately 5  ×  105 cells before 
ultrasound treatment.
Step 3 Cells were washed twice with 1  mL PBS, and 
1 mL 10 % FBS DMEM medium was added to ensure 
the volume before ultrasound treatment in each well 
in a 12-well plate. Fifty microliters of gold NP solu-
tion (BBI International Co.; 10  nm; Au stock con-
centration of 50 μg/mL) was added into the wells to 
achieve a final concentration of 2.5 μg/mL of Au NPs. 
In the other testing group, 50 μL of polyvinyl alcohol 
(PVA)-coated magnetic NPs (with a size of less than 
7 nm) were prepared by chemical co-precipitation of 
Fe(II)/Fe(III) salts to reach a final iron concentration 
of 60 μg/mL in the cell suspension.
Step 4 Ultrasound treatment The Sonablate-500 (Focus 
Surgery Inc., USA) was chosen as the ultrasound 
source for cell irradiation. The dual-element self-
focusing transducer was used in therapy mode with 
a 4-MHz resonant frequency and a 4-cm focal length. 
The probe was placed in a water tank with 4.5  L of 
degassed water for cell irradiation. Distilled water 
was obtained from a Millipore Q Synthesis A10 water 
purification system (resistivity  =  18  MOhm  cm−1, 
TOC = 3 ppb) and was degassed for 3 h using an on-
line membrane vacuum degasser (ERC 3000  W/N, 
Endeavor Responsibility Challenge Co, Japan). The 
Table 3 Percentage of  live MCF-10A and  MDA-MB-231 
cells in separate monolayers treated with US and magnetic 
NPs, averaged for five similar experiments
Cell line Percentage of  










MCF‑10A 81.4 ± 2.7 66.3 ± 4.8 53 ± 7.1
MDA‑MB‑231 82.6 ± 3.4 55.4 ± 5.1 34.8 ± 9.8
Fig. 4 TEM images of H‑184B5F5/M10 normal breast cells (a–c) and MDA‑MB‑231 breast cancer cells (d–f) cells, where a and d are control samples; 
b and e correspond to cells treated with US; c and f show the cells after combined treatment with US and magnetic NPs
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oxygen concentration in the water was measured 
prior to the experiments using an oxygen (dissolved) 
CHEMets Kit (K-7512, CHEMetrics Inc., USA) and 
was estimated to be 2–3 ppm. The water temperature 
in the tank was maintained in the range of 24–25 °C. 
The ultrasound power was adjusted using the soft-
ware for the Sonablate-500. The shape of the ultra-
sound focal spot was a 3-mm-wide by 12-mm-high 
prolate spheroid. The transducer was operated in 
the scanning mode and irradiated 25 spots (5 ×  5) 
in the 15 × 15-mm area under a well for 3 min 45 s. 
Thus, the treated region had a 3D 15 × 15 × 12-mm 
rectangular shape and was centered under the well. 
However, the center of the focal spot (with the maxi-
mum ultrasound intensity) was fixed at a distance of 
3 mm under the culture plate’s surface. Each point of 
the plate surface was irradiated with US for 3 s. The 
size and location of the treated zone was similar for 
each well in the culture plate. The temperature of 
the culture medium in a well was measured after US 
treatment using a thermocouple, and the tempera-
ture change was found to be less than 0.1  °C. Thus, 
the average thermal effect during US treatment of 
cells was negligible. For US experiments, a power of 
8  W was used, according to the read-out from the 
Sonablate-500 software. For the clinical treatment of 
prostate cancer, an US power of ~40  W is typically 
used. A corresponding total of 5.8 W radiated acous-
tic power was measured for an 8-W reading from 
the Sonablate software with a radiation force balance 
unit (UPM-DT-100AV, Ohmic Instruments Co.). A 
calibrated needle hydrophone (HNA-0400, Onda, 
CA, USA) was used to estimate the spatial-average 
temporal-average intensity, ISATA.
Co‑culture and cell analysis
For US-treated co-cultures of BEAS-2B and A549 cells, 
the numbers of attached cells were analyzed by optical 
microscopy. The attached cells were washed with 1  mL 
of PBS, followed by washing with an additional 1 mL of 
PBS with 0.1 mL of 0.4 % trypan blue for 5 min. Phase-
contrast images of the attached cell monolayers were 
obtained via optical microscopy (Olympus IX71, USA) 
at 200× magnification and a digital camera (Olympus 
DP70). A mercury lamp (U-LH100HG) was used to pro-
duce separate fluorescence images of the cells modified 
with green and red fluorescent proteins. Cells stained 
blue were counted as dead cells under high magnifica-
tion. Transparent cells were counted as live cells. The 
percentage of dead cells was determined by counting all 
the dead cells divided by the number of cells counted 
in a high-power field. Five fields were counted, with the 
means and standard deviations shown relative to those of 
the controls.
Flow cytometry analysis
To collect ultrasound-treated cells for flow cytometry 
analysis, the medium was removed and washed in 0.5 mL 
PBS; 0.5 mL trypsin was added to detach the cells. Cells 
were harvested with treated medium, separated by 
Fig. 5 TEM image of nanogold used in this experiment
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pipetting several times and premixed with 1  μg  mL−1 
of propidium iodide (Sigma Aldrich, USA) before flow 
cytometry analysis by a BD FACS Canto II system (BD 
Biosciences, USA) using a 488-nm laser for excitation 
and a PE channel for fluorescence detection. The num-
bers of live cells (Q4) were measured for control and 
ultrasound-treated cells using BD FACS Diva software 
version 6.0.
Transmission electron microscopy (TEM) of cells
Transmission electron microscopy was used to obtain 
images of H-184B5F5/M10 healthy breast cells and 
MDA-MB-231 breast cancer cells using the following 
procedure. The controls and US-treated cells were col-
lected and fixed in 2.5 % glutaraldehyde and 0.1 M caco-
dylate buffer for 2 h at 4 °C. The cells were washed twice 
for 15 min in the cacodylate buffer. A secondary fixation 
was performed in 1 % osmium tetroxide for 1 h at 4 °C, 
followed by two additional 15-min washes in the same 
buffer. After dehydration, the material was embedded 
in Spurr’s resin. The resin was first diluted in acetone 
(1:1) and incubated at 4  °C with agitation for 2  h and 
then diluted in acetone (1:3) and incubated at 4  °C with 
agitation for 24  h. The pellet was transferred to pure 
Spurr’s resin and incubated at 60 °C for 48 h until com-
pletely polymerized. Sections measuring 70–90 nm were 
obtained using a Leica EM UC 7 ultra-microtome (Leica 
Microsystems GmbH). The sections were then placed 
on copper grids and were studied under a TEM (TEM 
Hitachi H-7000, High-Technologies Co. Japan).
ICP‑MS analysis of NP uptake by cells
Four cell lines (MDA-MB-231, MCF-10A, A549, and 
BEAS-2B) were seeded in 12-well plates (5  ×  105 cells 
per well) in different culture media and maintained in 
a humidified incubator for 24  h at 37  °C and 5  % CO2. 
MDA-MB-231 breast cancer cells were cultured with 
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10 % fetal calf serum (FCS). MCF-10A nor-
mal breast cells were grown in DMEM/Ham’s F-12 with 
5 % FBS, 10 μg mL−1 insulin, 5 μg mL−1 hydrocortisone, 
20  ng  mL−1 EGF and 100  ng  mL−1 cholera toxin. A549 
lung cancer cells were grown in RPMI 1640 medium sup-
plemented with 10  % FBS. BEAS-2B normal lung cells 
were cultured in BEGM medium. The culture medium 
was replaced with 1 mL of serum-free DMEM. Gold or 
magnetic NPs were added to the cell suspensions at the 
same concentrations used for the ultrasound experiment. 
The cell cultures were incubated with NPs for 30 min at 
37 °C with 5 % CO2 and washed three times with phos-
phate-buffered saline (PBS); 1  mL of concentrated HCl 
was added to every well, and the mixture was heated to 
70 °C for 10 min. Then, samples were dissolved 10 times 
in double-distilled water and analyzed using ICP-MS 
(Thermo Scientific XSERIES 2) to determine the amount 
of gold and iron in the cells.
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